Stiripentol bulk supplier for pharma manufacturers

Stiripentol 250 mg, 500 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules / Oral Suspension

Available Strengths: 250 mg, 500 mg

Reference Brands: Diacomit (UES/EU)

Category: Neurology

Stiripentol is a Neurology product available as Capsules / Oral Suspension in strengths 250 mg, 500 mg. It corresponds to the reference brand Diacomit (UES/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Stiripentol is an anticonvulsant medication used for the treatment of Dravet syndrome, a rare and severe genetic epilepsy that begins in infancy and is characterized by refractory seizures. Marketed under the brand name Diacomit, stiripentol is approved in the European Union as an adjunctive therapy in combination with clobazam and valproate for patients whose generalized tonic-clonic seizures are not adequately controlled with standard treatment.

Stiripentol exerts its antiepileptic effects by enhancing gamma-aminobutyric acid (GABA)–mediated neurotransmission in the central nervous system, helping to reduce neuronal excitability. In addition, it inhibits specific cytochrome P450 enzymes, increasing the plasma concentrations and therapeutic effectiveness of co-administered antiepileptic drugs such as clobazam. This synergistic action contributes to improved seizure control in patients with severe myoclonic epilepsy in infancy.

The medication is administered orally in capsule form or as a powder for oral suspension and is prescribed under specialist supervision due to its potential for drug–drug interactions. Stiripentol plays a critical role in the long-term management of Dravet syndrome, helping reduce seizure frequency and severity in affected patients.

Stiripentol — third party manufacturing & bulk supply

Stiripentol 250 mg, 500 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Stiripentol is supplied as Capsules / Oral Suspension — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Stiripentol listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Stiripentol →

Back to Listing

Frequently Asked Questions

Stiripentol is used as an adjunctive treatment for seizures associated with Dravet syndrome, a rare and severe form of childhood epilepsy. It is prescribed in combination with clobazam and valproate when seizures are not adequately controlled by standard therapy.

Stiripentol is a synthetic antiepileptic compound formulated for oral administration in capsule form or as a powder for oral suspension.

The trade name of stiripentol is Diacomit.

Stiripentol under the brand name Diacomit is manufactured and marketed by Biocodex.

The generic name is stiripentol.

The brand name is Diacomit.

Stiripentol is manufactured in facilities approved by regulatory authorities, primarily in Europe, in compliance with international pharmaceutical manufacturing standards.